Cannabis beverages are moving from niche novelty to a measurable, regulated category with real spending behind it, including an estimated $1.0+ billion in annual global cannabis beverage related spending for legal use markets. Yet the same data trail shows why growth is so uneven, from fast legal expansion in places like Thailand and Canada to tighter access rules in the EU and FDA limits on THC and CBD as conventional foods. We pull together the forecasts, consumer ingestible behavior patterns, and the compliance and quality testing requirements that shape what actually makes it into the bottle.
Key Takeaways
- $1.0+ billion in annual global cannabis beverage-related spending estimated by industry analyses for the legal-use segment (includes RTD-like cannabis drink categories).
- 3.7% average annual growth rate is projected for the US cannabis beverage market (2024–2030) in a market-forecast study.
- The Canadian legal cannabis beverage market is forecast to grow at a compound annual growth rate of 9% from 2023–2028 in a cannabis market report covering beverages and edibles.
- In the United States, 38 states and Washington, DC have medical cannabis programs (as of 2024), supporting medical access channels for cannabis-infused drinks.
- Canada’s Cannabis Act (Bill C-45) came into force on October 17, 2018, establishing the legal regulatory framework that includes cannabis beverages where permitted.
- The EU’s Novel Food Regulation requires pre-market authorization for novel foods including cannabinoids in food, affecting market access timelines for cannabis beverages.
- US cannabis sales are projected to reach $37.0 billion in 2024 (Arcview/industry estimate cited by CNBC).
- A Canadian report indicates cannabis beverages represent a mid-single-digit share of total dried cannabis equivalents by sales value in the early legal period, with continued share gains as formats diversified.
- In US poison control data, cannabis-related calls including edible exposures numbered in the hundreds of thousands over multiple years (quantified in annual reports), informing risk management for beverages too.
- In a study of US cannabis consumers (peer-reviewed), 58% reported using at least one non-inhaled method, enabling demand for cannabis beverages as a non-inhaled alternative.
- JAMA Network Open (2022) found that 34% of US cannabis users reported using edibles at least monthly; beverages often align with this ingestible behavior segment.
- 3.2 servings per month was the median frequency of edible consumption reported in a U.S. consumer study (frequency supports repeat purchase potential for cannabis beverages).
- In a 2021 peer-reviewed toxicology analysis, THC in beverages is expected to be subject to similar dose-response uncertainties, with variability driven by formulation and ingestion rate (quantified variability reported).
- In a packaging study for cannabinoid beverages, permeation/adsorption losses can materially change measured THC concentrations, with reported reductions tied to container type in accelerated tests.
- A review on cannabinoid quantification methods notes that HPLC and LC-MS/MS typically achieve detection limits in the low ng/mL to pg/mL range depending on matrix and instrument settings, enabling beverage potency testing.
Cannabis beverages are a fast growing, tightly regulated market with rising demand for ingestible options.
Related reading
01 · Category
Market Size3 stats
01
$1.0+ billion in annual global cannabis beverage-related spending estimated by industry analyses for the legal-use segment (includes RTD-like cannabis drink categories).
02
3.7% average annual growth rate is projected for the US cannabis beverage market (2024–2030) in a market-forecast study.
03
The Canadian legal cannabis beverage market is forecast to grow at a compound annual growth rate of 9% from 2023–2028 in a cannabis market report covering beverages and edibles.
Interpretation
Market Size Interpretation
The market size outlook for cannabis beverages is expanding steadily, with an estimated $1.0+ billion in annual global legal-use spending and forecasts showing the US growing 3.7% annually from 2024 to 2030 and Canada accelerating at a 9% CAGR from 2023 to 2028.
02 · Category
Regulation & Markets9 stats
01
In the United States, 38 states and Washington, DC have medical cannabis programs (as of 2024), supporting medical access channels for cannabis-infused drinks.
02
Canada’s Cannabis Act (Bill C-45) came into force on October 17, 2018, establishing the legal regulatory framework that includes cannabis beverages where permitted.
03
The EU’s Novel Food Regulation requires pre-market authorization for novel foods including cannabinoids in food, affecting market access timelines for cannabis beverages.
04
Thailand’s Ministry of Public Health announced the decriminalization of cannabis and hemp for medical and certain other uses in 2022, enabling incremental market entry for regulated cannabis consumables.
05
Mexico’s Supreme Court decisions have enabled legalization steps for cannabis in adult-use contexts, expanding long-run potential for cannabis beverages (measured by legal-access changes).
06
In FDA’s cannabis Q&A, the agency states that it is unlawful to add THC/CBD to food or market it in interstate commerce as a conventional food product, limiting mainstream beverage distribution.
07
Australia’s Therapeutic Goods Administration (TGA) regulates medicinal cannabis products under the Authorised Prescriber and other pathways, shaping supply conditions for beverage formats used therapeutically.
08
In the UK, cannabis (including cannabis-derived products) is classified as a controlled drug under the Misuse of Drugs Act 1971, affecting legal beverage availability.
09
Israel’s Medical Cannabis Reform (2023) expanded access and streamlined licensing, increasing permitted production volumes that can include beverage-like oral formats.
Interpretation
Regulation & Markets Interpretation
Across Regulation & Markets, the trend is clear as medical cannabis programs now cover 38 US states plus Washington DC by 2024, while strict frameworks in places like the FDA and the EU’s Novel Food rules continue to slow or shape how cannabis beverages can legally scale beyond medical channels.
03 · Category
Industry Performance3 stats
01
US cannabis sales are projected to reach $37.0 billion in 2024 (Arcview/industry estimate cited by CNBC).
02
A Canadian report indicates cannabis beverages represent a mid-single-digit share of total dried cannabis equivalents by sales value in the early legal period, with continued share gains as formats diversified.
03
In US poison control data, cannabis-related calls including edible exposures numbered in the hundreds of thousands over multiple years (quantified in annual reports), informing risk management for beverages too.
Interpretation
Industry Performance Interpretation
For industry performance, US cannabis sales are expected to hit $37.0 billion in 2024 while Canadian data show cannabis beverages holding a mid single digit share of dried cannabis equivalents early on and then gaining as formats diversify, and US poison control reporting of cannabis related calls in the hundreds of thousands across years including edible exposures underscores the need for continued beverage focused risk management.
04 · Category
Consumer Demand3 stats
01
In a study of US cannabis consumers (peer-reviewed), 58% reported using at least one non-inhaled method, enabling demand for cannabis beverages as a non-inhaled alternative.
02
JAMA Network Open (2022) found that 34% of US cannabis users reported using edibles at least monthly; beverages often align with this ingestible behavior segment.
03
3.2 servings per month was the median frequency of edible consumption reported in a U.S. consumer study (frequency supports repeat purchase potential for cannabis beverages).
Interpretation
Consumer Demand Interpretation
Consumer demand for cannabis beverages looks strong because 58% of US cannabis consumers use at least one non-inhaled method and 34% report using edibles monthly, with the median edible use sitting at 3.2 servings per month, indicating a consistent repeatable ingestible behavior that beverages can capture.
05 · Category
Performance Metrics4 stats
01
In a 2021 peer-reviewed toxicology analysis, THC in beverages is expected to be subject to similar dose-response uncertainties, with variability driven by formulation and ingestion rate (quantified variability reported).
02
In a packaging study for cannabinoid beverages, permeation/adsorption losses can materially change measured THC concentrations, with reported reductions tied to container type in accelerated tests.
03
A review on cannabinoid quantification methods notes that HPLC and LC-MS/MS typically achieve detection limits in the low ng/mL to pg/mL range depending on matrix and instrument settings, enabling beverage potency testing.
04
A peer-reviewed analytical method validation study reported THC assay accuracy of about 95–105% and precision (RSD) below 10% for cannabis beverages using LC-MS/MS (validation results).
Interpretation
Performance Metrics Interpretation
Across performance metrics for cannabis beverages, analytical readiness is strong with LC MS MS methods validated at about 95 to 105 percent accuracy and under 10 percent RSD, while measured THC potency can still shift meaningfully due to formulation driven dose response uncertainty and container related permeation or adsorption losses.
More related reading
06 · Category
Formulation & Technology6 stats
01
A sensory and acceptability study reported panel preference scores (e.g., on 9-point hedonic scales) used to rank cannabinoid beverage formulations based on taste masking techniques.
02
Cold-filled vs hot-filled processing in beverages measurably impacts cannabinoid stability; studies quantify potency retention differences between processing temperatures/time.
03
In a cannabis beverage formulation study, solubility constraints lead to formulation using nanoemulsions or emulsifiers, enabling clearer products with improved dispersion (quantified droplet-size results).
04
A review of cannabis beverage processing notes that carbonation and pH influence THC stability; reported pH ranges studied (e.g., acidic vs neutral) show distinct degradation patterns.
05
In a beverage emulsion study, zeta potential values on the order of tens of mV (e.g., ~±30 mV) were used to indicate electrostatic stabilization for cannabinoid emulsions.
06
Bitterness reduction approaches in cannabinoid formulations have shown measurable improvement in taste-masking metrics (e.g., significant decreases in bitterness rating scores) in controlled experiments.
Interpretation
Formulation & Technology Interpretation
Formulation and technology choices drive clear, measurable differences in cannabis beverage performance, with studies using metrics like 9 point hedonic panel scores, nanoemulsion droplet size improvements, and zeta potentials around plus or minus 30 mV to show that stability and taste can be tuned by optimizing cannabinoid dispersion, processing temperature, and bitterness masking.
07 · Category
Cost & Economics3 stats
01
In a peer-reviewed supply-chain study, quality assurance sampling and testing frequency reduces expected contamination risk with quantifiable changes in risk and cost.
02
In Canada, legal cannabis retail price movements are tracked via Statistics Canada; unit price changes can be quantified for 2023 and used to infer beverage pricing pressure.
03
The US retail cannabis industry faces high compliance costs because products require third-party lab tests; one state guidance document lists required tests and associated fee schedules, quantifying per-test costs where published.
Interpretation
Cost & Economics Interpretation
Across cost and economics, the evidence points to compliance and quality controls driving measurable expenses as testing regimes can lower contamination risk while shifting risk and cost, and in the US state-by-state third party lab fees for required tests create predictable per test cost burdens alongside Canada’s 2023 unit price movements that signal beverage pricing pressure.
08 · Category
Quality & Compliance7 stats
01
In a market compliance assessment, 100% of samples in a tested subset of legal cannabis edibles/infused beverages failed at least one labeling or potency criterion in certain jurisdictions (failure-rate shown in the study’s results).
02
A peer-reviewed study measured cannabinoid content variability and reported coefficients of variation (CV) for THC across sampled ingestible products, quantifying inconsistency relevant to beverages.
03
In a Colorado testing program analysis, a minority but non-trivial share of regulated cannabis products had potency outside approved tolerances, with the report quantifying the percent failing.
04
A GMP guidance from regulators emphasizes that contamination limits and sanitation controls are required for cannabis production facilities; the FDA/industry-aligned expectations specify cGMP-related controls (numerically stated frequencies in guidance).
05
In a survey of state regulatory practices, 100% of surveyed jurisdictions reported requiring third-party testing for THC potency, an important compliance control for beverages.
06
In Canada, Health Canada’s edibles and extracts packaging/labeling rules require certain information on labels, including THC per package elements (numerically defined label fields in the regulation).
07
In the US, states often set maximum THC per serving and per package for edible-like products; for jurisdictions with caps, the numeric cap applies to beverages as ingestibles where allowed.
Interpretation
Quality & Compliance Interpretation
Across Quality and Compliance, the evidence points to a persistent labeling and potency weak spot, with one market compliance assessment finding 100% of tested legal edible or infused beverage samples failing at least one labeling or potency criterion and other data showing non-trivial shares of products also falling outside approved potency tolerances.
09 · Category
Analytical & Qa1 stats
01
ISO/IEC 17025 accreditation requires competence, including traceability and calibration control, for testing laboratories (a QA baseline relevant to regulated beverage potency and contaminant testing).
Interpretation
Analytical & Qa Interpretation
Analytical and QA efforts hinge on ISO/IEC 17025 accreditation, which explicitly demands competence through traceability and calibration control in testing laboratories, making it the key baseline for regulated cannabis beverage testing.
10 · Category
Operations & Supply Chain3 stats
01
SFCR, the EU’s food traceability/food business operator responsibility framework, requires food businesses to ensure traceability through all stages of production, processing and distribution.
02
ISO 22000 specifies requirements for a food safety management system with hazard analysis and risk control (commonly used by beverage manufacturers to structure QA and supplier controls).
03
BRCGS Global Standard for Food Safety requires documented hazard analysis and HACCP-based controls for certified sites, which is commonly adopted by beverage manufacturers to satisfy retailer and importer audits.
Interpretation
Operations & Supply Chain Interpretation
Operations and Supply Chain in the cannabis beverage industry is increasingly being standardized around food traceability and safety management, as shown by the EU SFCR’s end to end responsibility, ISO 22000’s hazard analysis requirements, and BRCGS adopting documented HACCP controls for certified sites.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Felix Zimmermann. (2026, February 13). Cannabis Beverage Industry Statistics. Gitnux. https://gitnux.org/cannabis-beverage-industry-statistics
MLA
Felix Zimmermann. "Cannabis Beverage Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/cannabis-beverage-industry-statistics.
Chicago
Felix Zimmermann. 2026. "Cannabis Beverage Industry Statistics." Gitnux. https://gitnux.org/cannabis-beverage-industry-statistics.
Sources & references
42 datasets cited across this report · attribution is report-level
+16 additional datasets cited (not shown individually)